Clinical Trial Update: The Edinburgh Lung Fibrosis Molecular Endotyping (ELFMEN) Study

View source ↗

Summary

This clinical trial update reports that the Edinburgh Lung Fibrosis Molecular Endotyping (ELFMEN) study is actively recruiting by invitation, focusing on molecu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asbestosis
• Idiopathic Pulmonary Fibrosis
• Interstitial Lung Disease

Snippet

Sponsor: University of Edinburgh | Conditions: Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease | Status: ENROLLING_BY_INVITATION